For more than 30 years, AXONAL BIOSTATEM supported their clients in the design, implementation and analysis of their clinical research projects and non-interventional studies. While offering a European and international coverage, their medical and scientific expertise as well as their ability to adapt to the specificities of each project, helped them become a solid and sustainable company.
Their main goals consist of supporting medical research stakeholders to obtain reliable and honest data, facilitating early patient access to innovative therapies and reducing the environmental impact of their activities.
Learn more: www.axonalbiostatem.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
February 29, 2024
4 and 5 march 2024 TELEMEDICINE TECHNOLOGIES is delighted to announce its participation in the upcoming ACDM24 conference, the largest European event in clinical data management for 2024! Join us in Copenhagen from March 3rd to 5th, where industry leaders and experts will gather to explore the latest trends in the field. Christophe Golenvaux and […]
February 29, 2024
Bio Pharm International FDA’s Drug Safety Priorities FY23 describes the center’s key safety programs and activities involved in promoting and protecting public health. On Feb. 15, 2024, FDA’s Center for Drug Evaluation and Research (CDER) released its report, Drug Safety Priorities FY23. The report describes the center’s key safety programs and activities involved in promoting and […]
February 29, 2024
Fierce Biotech In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, multidisciplinary, and cost-effective approaches. Pathways have become a critical strategy for both physicians and payers to streamline treatment decision-making, standardize evidence-based care, improve patient outcomes […]